Adamas Pharmaceuticals: Q4 Earnings Insights

By Benzinga6 days ago

Shares of Adamas Pharmaceuticals (NASDAQ:ADMS) rose in after-market trading after the company reported Q4 results.

Quarterly Results

Earnings per share rose 22.89% over the past year to ($0.64), which missed the estimate of ($0.51).

Revenue of $21,010,000 rose by 28.52% from the same period last year, which beat the estimate ...

Full story available on Benzinga.com

Continue read on benzinga.com